Nebivolol hydrochloride - Резултати от търсенето

a-s medication solutions - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol 5 mg - bystolic is indicated for the treatment of hypertension, to lower blood pressure [see clinical studies ( 14.1)]. bystolic may be used alone or in combination with other antihypertensive agents [see drug interactions ( 7)]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with bystolic. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of t

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

nebivolol 2.5mg tablets

sigma pharmaceuticals plc - nebivolol hydrochloride - oral tablet - 2.5mg

Ирландия - английски - HPRA (Health Products Regulatory Authority)

nebivolol 10 mg tablets

medreich plc - nebivolol - tablet - 10 milligram(s) - nebivolol